SpyGlass Pharma, Inc. (SGP): Cash & Equivalents
$96.36M
As of 2025-12-31
$223.14M
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $96.36M | +492.3% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $16.27M | n/a | 2026-03-26, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | 2025-12-31 | $96.36M | +492.3% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $91.97M | -23.6% |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $34.69M | +55.8% |
| Fractyl Health, Inc. (GUTS) | 2025-12-31 | $81.54M | +20.9% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $21.80M | -21.5% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $85.76M | +3.4% |
| Iradimed Corp (IRMD) | 2025-12-31 | $51.16M | -2.1% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $43.45M | +34.1% |
| Alpha Tau Medical Ltd. (DRTS) | 2025-12-31 | $12.20M | -11.1% |
Compare SGP, SGHT, OBIO, GUTS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗